After-Hours Earnings Report for November 12, 2012 : HOLX, JEC, CSOD, TROX, WX, ESE, BAGL, GFA, GLAD, FRF, NQ, TSPT

By
A A A

The following companies are expected to report earnings after hours on 11/12/2012. Visit our Earnings Calendar for a full list of expected earnings releases.

Hologic, Inc. ( HOLX ) is reporting for the quarter ending September 30, 2012. The medical instruments company's consensus earnings per share forecast from the 18 analysts that follow the stock is $0.36. This value represents a 5.88% increase compared to the same quarter last year. In the past year HOLX has met analyst expectations once and beat the expectations the other two quarters. Zacks Investment Research reports that the 2012 Price to Earnings ratio for HOLX is 14.72 vs. an industry ratio of 4.70, implying that they will have a higher earnings growth than their competitors in the same industry.

Jacobs Engineering Group Inc. ( JEC ) is reporting for the quarter ending September 30, 2012. The engineering company's consensus earnings per share forecast from the 16 analysts that follow the stock is $0.80. This value represents a 8.11% increase compared to the same quarter last year. JEC missed the consensus earnings per share in the 1st calendar quarter by -12.16%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for JEC is 13.40 vs. an industry ratio of 13.50.

Cornerstone OnDemand, Inc. ( CSOD ) is reporting for the quarter ending September 30, 2012. The computer software company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.09. This value represents a 12.50% increase compared to the same quarter last year. The last two quarters CSOD had negative earnings surprises; the latest report they missed by -7.69%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for CSOD is -58.74 vs. an industry ratio of 4.70.

Tronox Limited ( TROX ) is reporting for the quarter ending September 30, 2012. The chemical company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.45. This value represents a -64.00% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for TROX is 6.31 vs. an industry ratio of 12.40.

Wuxi Pharmatech (Cayman) Inc. ( WX ) is reporting for the quarter ending September 30, 2012. The drug company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.25. This value represents a -10.71% decrease compared to the same quarter last year. In the past year WX has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2012 Price to Earnings ratio for WX is 13.70 vs. an industry ratio of 3.80, implying that they will have a higher earnings growth than their competitors in the same industry.

ESCO Technologies Inc. ( ESE ) is reporting for the quarter ending September 30, 2012. The electrical instrument company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.62. This value represents a 8.77% increase compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for ESE is 21.02 vs. an industry ratio of 11.10, implying that they will have a higher earnings growth than their competitors in the same industry.

Einstein Noah Restaurant Group, Inc. ( BAGL ) is reporting for the quarter ending September 30, 2012. The restaurant company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.21. This value represents a 16.67% increase compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for BAGL is 15.58 vs. an industry ratio of 15.10, implying that they will have a higher earnings growth than their competitors in the same industry.

Gafisa SA ( GFA ) is reporting for the quarter ending September 30, 2012. The building (residential/commercial) company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.04. This value represents a -71.43% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for GFA is 91.50 vs. an industry ratio of 23.60, implying that they will have a higher earnings growth than their competitors in the same industry.

Gladstone Capital Corporation ( GLAD ) is reporting for the quarter ending September 30, 2012. The financial services company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.24. This value represents a 4.35% increase compared to the same quarter last year. GLAD missed the consensus earnings per share in the 4th calendar quarter by -4.55%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for GLAD is 9.21 vs. an industry ratio of 25.10.

Fortegra Financial Corporation ( FRF ) is reporting for the quarter ending September 30, 2012. The insurance company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.26. This value represents a 36.84% increase compared to the same quarter last year. FRF missed the consensus earnings per share in the 1st calendar quarter by -10.53%. The "days to cover" for this stock exceeds 22 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for FRF is 9.02 vs. an industry ratio of 7.40, implying that they will have a higher earnings growth than their competitors in the same industry.

NQ Mobile Inc. ( NQ ) is reporting for the quarter ending September 30, 2012. The computer software company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.03. This value represents a -66.67% decrease compared to the same quarter last year. The "days to cover" for this stock exceeds 12 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for NQ is 44.27 vs. an industry ratio of 4.70, implying that they will have a higher earnings growth than their competitors in the same industry.

Transcept Pharmaceuticals, Inc. ( TSPT ) is reporting for the quarter ending September 30, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.03. This value represents a -91.89% decrease compared to the same quarter last year. In the past year TSPT has met analyst expectations once and beat the expectations the other three quarters. The "days to cover" for this stock exceeds 14 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for TSPT is -7.13 vs. an industry ratio of 2.60.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Earnings


NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

Most Active by Volume

83,946,369
  • $16.40 ▼ 1.20%
65,919,147
  • $102.99 ▲ 0.51%
63,004,409
  • $42 ▲ 4.53%
42,618,740
  • $7.93 ▼ 2.94%
41,388,613
  • $78.37 ▼ 0.41%
40,438,996
  • $3.81 ▲ 14.76%
39,835,674
  • $12.32 ▲ 2.41%
38,147,728
  • $12.83 ▼ 2.80%
As of 10/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com